Navigation Links
Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease

Studies Show Increased Enzyme Levels in Two Most Common Mutations

CRANBURY, N.J., March 20, 2007 /PRNewswire/ -- Amicus Therapeutics, a biopharmaceutical company developing small molecule, orally-administered pharmacological chaperones for the treatment of a range of human genetic diseases, announced today that it will present the results of preclinical studies of Plicera(TM) (isofagomine tartrate, AT2101) for Gaucher disease at the of Medical Genetics (ACMG) annual meeting March 21-25 in Nashville, TN. The data demonstrate the ability of Plicera to increase levels of the target enzyme in cells derived from a patient with the N370S mutation and in mice that express the L444P mutation. The N370S and the L444P are the two most common mutations associated with Gaucher disease. Additional data from both studies will also be presented.

Plicera is designed to selectively bind to and stabilize GCase, the enzyme deficient in Gaucher disease. This deficiency leads to lysosomal accumulation of glucocerebroside inside certain cells, which is believed to cause the various symptoms of Gaucher disease. Plicera facilitates proper trafficking of the enzyme to the lysosomes, the compartments in the cell where it is needed to break down glucocerebroside.

The following is a summary of the preclinical Plicera data being presented at ACMG.

    - In vitro exposure to Plicera increased transport of GCase to the

      lysosomes in cells derived from a patient with the N370S mutation.

      Once in the lysosome, the enzyme was stable and active for more than 3

      days after Plicera was removed. The N370S is the most common mutation

      associated with Gaucher disease in the Western world.  These studies

      were published in the September 12, 2006 issue of the Proceedings of the

      National Academy of Sciences (PNAS).


    - Oral administration of Plicera resulted in a dose-dependent increase of
'"/>




Page: 1 2 3

Related medicine technology :

1. Amicus Therapeutics Presents Positive Results From Phase 1 Clinical Studies of Plicera for Gaucher Disease
2. Amicus Therapeutics Presents Data From Preclinical and Phase 1 Studies of Amigal for Fabry Disease
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
5. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
6. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
7. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
8. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
(Date:3/3/2015)...   Surefire Medical, Inc. today announced ... Surefire Infusion System with an end hole microcatheter.  ... cancer, using the Surefire resulted in statistically significant ... with significantly decreased uptake in normal liver tissue. ... Society of Interventional Radiology (SIR) meeting in ...
(Date:3/3/2015)... March 3, 2015  UnaliWear announces the market preview ... for seniors that guards against wandering and provides support ... new wearable – the Kanega watch ( http://www.UnaliWear.com ) ... use an easy speech interface rather than buttons, use ... human input. The watch goes wherever ...
(Date:3/3/2015)... , March 3, 2015  Michigan brothers Dominique ... condition called arrhythmogenic right ventricular dysplasia, or ARVD, a disease ... of sudden death among young athletes. In 2007, ... a basketball game. They later tested Dominique and found his ... a February 19, 2015 story in The Ann Arbor ...
Breaking Medicine Technology:Clinical Trial Comparing the Surefire Infusion Device to an End Hole Catheter Finds Surefire Increases Tumor Uptake and Decreases Non-Target Embolization In Every Patient, Multiple Liver Cancer Types 2UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3
(Date:3/4/2015)... March 04, 2015 Nurses, healthcare professionals ... American Cannabis Nurses Association (ACNA) to learn about why ... wide array of illnesses and conditions. The one-day continuing ... is being offered on April 1 or April 2 ... was approved by the Ohio Nurses Association (OBN-001-91), an ...
(Date:3/3/2015)... Washington, DC (PRWEB) March 04, 2015 ... business into value-based payment contracts within the next few ... — and the significant chunk of health care spending ... Information Services, Inc.’s ACO Business News (ABN) tracks ... the context of a commercial accountable care organization (ACO)-type ...
(Date:3/3/2015)... On February 24, 2015, a Toledo, Ohio ... District Court for the Northern District of Ohio against ... insurance companies Balboa, QBE, and Newport Management. (See Amended ... , The Plaintiff, a Ms. Dolores Gorsuch, says her ... to buy too much insurance at rates that were ...
(Date:3/3/2015)... 2015 Risperdal lawsuits ( http://www.risperdallawsuit2014.com/ ... atypical antipsychotic medication continue to move forward in ... the South Carolina Supreme Court upheld a state ... Janssen Pharmaceuticals unit had deceptively marketed the medication ... Court’s February 25th decision characterized the company’s conduct ...
(Date:3/3/2015)... March 03, 2015 Loma Linda University ... health and well being, it will be offering new, ... its campuses. , Over the past year, a cross-section ... in creating dietary criteria, listening to vendors, sampling their ... entire organization. , Most recently, a food fair ...
Breaking Medicine News(10 mins):Health News:American Cannabis Nurses Association Announces Speaker Lineup for Educational Seminar in Cleveland 2Health News:American Cannabis Nurses Association Announces Speaker Lineup for Educational Seminar in Cleveland 3Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 2Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 3Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3Health News:Loma Linda University Health Rejuvenates Its Vending Machines with Healthier Selections 2
... Department of Health Services has issued a warning ... by Doctors. State health officials have pinned// down ... unlicensed parties and Internet vendors. ... "The physicians under investigation have failed to provide ...
... of Health received over $100,000 from drug companies in unauthorized ... reports in a newspaper on Sunday. ,The actions of ... during an internal review, which concluded that he was guilty ... to reports from the Los Angeles Times. ,The review ...
... MRSA affecting almost double the number of babies and children, ... medical circles//. ,The Health Protection Agency has ... form of blood infection, spurred by the super bug from ... a year old; it is getting well known that such ...
... seen a rapid increase in healthcare charges over the past ... only by the rising cost of living// but also by ... ,The government in 2003 revised the healthcare fee structure. ... of ‘free’ hospital visits. In fact, they even used to ...
... prolonged stress could lead to constant preoccupation heightened by an inability ... has revealed.// ,The survey also found that not ... with the rigors of coping with every day life. They are ... drinking, not even diet related issues. , ,Technology ...
... experts on the genetics of a potentially lethal heart ... athletes report they have greatly narrowed //the hunt for ... ,Their new findings, described in the July ... increase the accuracy of tests to identify those at ...
Cached Medicine News:Health News:Medical researcher Accused of 'serious misconduct' 2Health News:Escalating Healthcare charges in UAE 2Health News:Escalating Healthcare charges in UAE 3Health News:Closing in on Lethal Heart Rhythm in Young Athletes 2Health News:Closing in on Lethal Heart Rhythm in Young Athletes 3
The Radionics XKnife RT2 system provides a precise and versatile stereotactic radiation therapy solution....
The Primus linear accelerator is a fully digital, technologically advanced radiation therapy treatment delivery system. It can be configured for delivery of routine, 3-D conformal or IMRT treatments....
Clinac EX Platinum accelerators offer all the high performance features of the EX series and come standard with the latest high-precision dose sculpting technology for advanced tumor control....
... cost-effective, proven and reliable system. Varian ... rapid patient treatment, fastest beam-on times ... less than 500 milliseconds, pulse-to-pulse beam ... stability, greatest number of multileaf collimator ...
Medicine Products: